Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Costanza Paoletti

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Nature Nanotechnology|October 1, 2013
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheetsHyeun Joong Yoon, Tae Hyun Kim, Zhuo Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine StudyCostanza Paoletti, Jieling Miao, Emily M Dolce, et al.
Molecular Oncology|March 30, 2013
Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancerJeffrey B Smerage, G Thomas Budd, Gerald V Doyle, et al.
British Journal of Cancer|June 4, 2026
A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasmsT R Jeffry Evans, Natalie Cook, Anthony El-Khoueiry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2021
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 TrialCostanza Paoletti, William E Barlow, Erin F Cobain, et al.
Plos One|November 15, 2021
PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancerElizabeth P Darga, Emily M Dolce, Fang Fang, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 17, 2023
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)Mattias Bergqvist, Adrian Nordmark, Amy Williams, et al.
JCO Precision Oncology|January 12, 2023
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast CancerAfroditi Nanou, Jieling Miao, Frank A W Coumans, et al.
Molecular Oncology|May 15, 2016
Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistanceCostanza Paoletti, Jose M Larios, Maria C Muñiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2014
Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancerCostanza Paoletti, Maria C Muñiz, Dafydd G Thomas, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Nature Nanotechnology|October 1, 2013
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheetsHyeun Joong Yoon, Tae Hyun Kim, Zhuo Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine StudyCostanza Paoletti, Jieling Miao, Emily M Dolce, et al.
Molecular Oncology|March 30, 2013
Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancerJeffrey B Smerage, G Thomas Budd, Gerald V Doyle, et al.
British Journal of Cancer|June 4, 2026
A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasmsT R Jeffry Evans, Natalie Cook, Anthony El-Khoueiry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2021
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 TrialCostanza Paoletti, William E Barlow, Erin F Cobain, et al.
Plos One|November 15, 2021
PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancerElizabeth P Darga, Emily M Dolce, Fang Fang, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 17, 2023
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)Mattias Bergqvist, Adrian Nordmark, Amy Williams, et al.
JCO Precision Oncology|January 12, 2023
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast CancerAfroditi Nanou, Jieling Miao, Frank A W Coumans, et al.
Molecular Oncology|May 15, 2016
Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistanceCostanza Paoletti, Jose M Larios, Maria C Muñiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2014
Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancerCostanza Paoletti, Maria C Muñiz, Dafydd G Thomas, et al.
Pageof 3